Roar Mikalsen - HUMAN RISING - radiofri..

Professor Sir Michael Rawlins: The evidence was not there. It was not a lack of
experts. We had psychiatrists coming out of our ears. It was just the scientific evidence. This
is a very tricky area and even now the epidemiologists that we recruited specially to advise
us, on the balance of probabilities, think there is a causal link, but they are not 100 per cent
certain because there are all sorts of confounding issues that bedevil the interpretation of
the evidence. One of the difficulties is, when you take the confounding issues into account,
the relationship becomes smaller and smaller. Technically it is a very difficult area.” (sitat fra
SCIENTIFIC ADVICE, RISK AND EVIDENCE: HOW GOVERNMENT HANDLES THEM, House of
Commons Minutes of Oral Evidence Taken before the Science and Technology Committee, 1
Mars 2006. Q 203-204. I forbindelse med denne utskriften gjør forfatterne oppmerksom på
følgende: “The transcript is not yet an approved formal record of these proceedings. Any
public use of, or reference to the contents should make clear that neither Members nor
witnesses have had the opportunity to correct the record.”)
For å ytterligere spre forvirring rundt denne påståtte linken, kan vi også ta med i
regnestykket forskning som viser at cannabis kan ha en positiv effekt mot schizofreni:
I juni 2009 utgaven av Journal of Clinical Psychopharmacology, omtaler de for eksempel en
undersøkelse gjort av Rockland Psychiatric Center og New York University School of
Medicine, som viser at schizofrene pasienter som fikk 2.5- 5mg doser THC over åtte uker, i
det store og hele fikk et betydelig forbedret helsebilde: "Four of the 6 patients improved to a
clinically significant extent (after taking dronabinol)," researchers reported. "Three of the six
patients had a robust response, with modest to marked reductions in core psychotic
symptoms. Patients 1 and 2 showed improvement within several weeks of beginning the
medication, whereas patient 3 required 8 weeks to reach significant improvement. In
addition, robust improvement in overall functioning was also observed, with patients 1 to 3
changing from being gravely ill to being functioning individuals able to be discharged. Patient
4 had more limited improvement in that he was calmer, cooperative, and less aggressive but
had persistence of his core psychosis. Nevertheless, his overall functioning was significantly
improved. ... There were no clinically adverse effects."
I tillegg til denne undersøkelsen, refererer artikkelen også til andre undersøkelser:
”Previous studies assessing the use of marijuana in patients with schizophrenia have
produced mixed results. A 2007 German study reported improved cognition in patients who
used cannabis, and a 2008 Australian study found that patients diagnosed with
schizophrenia report experiencing subjective relief from pot. Critics of medical cannabis use
have argued that heavy marijuana use may exacerbate psychosis in patients with mental
illness. However, the largest trial ever conducted comparing cannabis using and non-using
schizophrenic patients reported no statistically significant "differences in syptomatology
between schizophrenic patients who were or were not cannabis users" after controlling for
patients' age, sex, and ethnicity.“
434